Neurofibromatosis Type 2
Rare Disease·MeSH: Neurofibromatosis 2
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 2/Phase 3(1)
Frequently asked questions
How many drugs are in development for Neurofibromatosis Type 2?
BioSniper tracks 1 drug in development for Neurofibromatosis Type 2 across 1 company.
How many clinical trials target Neurofibromatosis Type 2?
There are 3 clinical trials targeting Neurofibromatosis Type 2 tracked by BioSniper.
What is the prevalence of Neurofibromatosis Type 2?
The estimated prevalence of Neurofibromatosis Type 2 is approximately 30.0 per 100,000 population.
Deep-dive into Neurofibromatosis Type 2
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis